ANTI-EPHA2 ANTIBODY

Problem to be Solved It is intended to provide an antibody having an inhibitory activity against cell malignant transformation and/or tumor cell growth, etc. Solution The present invention provides an antibody which recognizes an epitope recognized by an antibody produced by a hybridoma SH348-1 (FER...

Full description

Saved in:
Bibliographic Details
Main Authors YAMAGUCHI JUNKO, OHTSUKA TOSHIAKI, URANO ATSUSHI, TAKIZAWA TAKESHI, NAKAHARA KAORI, AGATSUMA TOSHINORI, HASEGAWA JUN
Format Patent
LanguageEnglish
Korean
Published 23.01.2015
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract Problem to be Solved It is intended to provide an antibody having an inhibitory activity against cell malignant transformation and/or tumor cell growth, etc. Solution The present invention provides an antibody which recognizes an epitope recognized by an antibody produced by a hybridoma SH348-1 (FERM BP-10836) or a hybridoma SH357-1 (FERM BP-10837), an antibody produced by the hybridoma SH348-1 or the hybridoma SH357-1, an antibody obtained by humanizing the antibody produced by the hybridoma SH348-1 or the hybridoma SH357-1, a pharmaceutical agent comprising the antibody as an active ingredient, etc.
AbstractList Problem to be Solved It is intended to provide an antibody having an inhibitory activity against cell malignant transformation and/or tumor cell growth, etc. Solution The present invention provides an antibody which recognizes an epitope recognized by an antibody produced by a hybridoma SH348-1 (FERM BP-10836) or a hybridoma SH357-1 (FERM BP-10837), an antibody produced by the hybridoma SH348-1 or the hybridoma SH357-1, an antibody obtained by humanizing the antibody produced by the hybridoma SH348-1 or the hybridoma SH357-1, a pharmaceutical agent comprising the antibody as an active ingredient, etc.
Author AGATSUMA TOSHINORI
OHTSUKA TOSHIAKI
URANO ATSUSHI
YAMAGUCHI JUNKO
HASEGAWA JUN
TAKIZAWA TAKESHI
NAKAHARA KAORI
Author_xml – fullname: YAMAGUCHI JUNKO
– fullname: OHTSUKA TOSHIAKI
– fullname: URANO ATSUSHI
– fullname: TAKIZAWA TAKESHI
– fullname: NAKAHARA KAORI
– fullname: AGATSUMA TOSHINORI
– fullname: HASEGAWA JUN
BookMark eNrjYmDJy89L5WQQdvQL8dR1DfBwNFIAMZ38XSJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8d5CRgaGpgYGBhaWxoaMxcaoAh0IgsQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20150008931A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20150008931A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:34:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20150008931A3
Notes Application Number: KR20147036821
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150123&DB=EPODOC&CC=KR&NR=20150008931A
ParticipantIDs epo_espacenet_KR20150008931A
PublicationCentury 2000
PublicationDate 20150123
PublicationDateYYYYMMDD 2015-01-23
PublicationDate_xml – month: 01
  year: 2015
  text: 20150123
  day: 23
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies DAIICHI SANKYO COMPANY, LIMITED
RelatedCompanies_xml – name: DAIICHI SANKYO COMPANY, LIMITED
Score 2.9308934
Snippet Problem to be Solved It is intended to provide an antibody having an inhibitory activity against cell malignant transformation and/or tumor cell growth, etc....
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title ANTI-EPHA2 ANTIBODY
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150123&DB=EPODOC&locale=&CC=KR&NR=20150008931A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1Detih9TBkrfgrRpu_ahSD-pjrWlVJlPI21TGIobruLf9xo73dPeLjk4kpD7zN0F4I5alWZaeknQduBEY4VG8JZwwkzdspiKRrTIqpzERvSsPU31aQ_e17Uwok_ot2iOiBxVIr83Ql4v_4NYvsitXN0Xc5xaPIS57cudd4zWDUpi2XftIE38xJM9zx5ncpz94lDfWVRxdmAXDemRcNte3LYuZbmpVMIj2EuR3kdzDL23hQQH3vrvNQn2J92TN4Id961OQHLi_JEEaeSowxZ0E__1FG7DIPcigtRnf5uZjbPNpdAz6KObz89hWOmUc6OozZKNtFqtWMFqpuqFUVKFMU25gME2Spfb0Vdw2A7b4IFKB9BvPr_4NarTprgRp_ADuxZ06g
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNo1K1akHJLUieJocgeZKa5kGIUk9lNw8QxRYb8e87WVPtqbdhB4bdZWfmm9mdWYBb2SgV3VALAbFDJSiEKgKekkogumoYREIQzV5VRrEWPCmPM3XWg_d1LQzrE_rNmiOiRhWo7w2z18v_JJbL3lau7ugrDi0e_Nx0-S46RnSDlph3bdNLEzdxeMcxw4yPs18e-jtDFq0d2EWQrbNg6dlu61KWm07FP4S9FOV9NEfQe1twMHDWf69xsB91V95Idtq3OgbOivOJ4KWBJY1b0k7clxO48b3cCQSUPv9bzDzMNqcin0Ifw_xqCONSlatKo7VekHullkpCSU0klWqFLBKiiGcw2ibpfDv7GgZBHk3n00kcXsBBy2oTCZI8gn7z-VVdomtt6BXbkR9d-nfa
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-EPHA2+ANTIBODY&rft.inventor=YAMAGUCHI+JUNKO&rft.inventor=OHTSUKA+TOSHIAKI&rft.inventor=URANO+ATSUSHI&rft.inventor=TAKIZAWA+TAKESHI&rft.inventor=NAKAHARA+KAORI&rft.inventor=AGATSUMA+TOSHINORI&rft.inventor=HASEGAWA+JUN&rft.date=2015-01-23&rft.externalDBID=A&rft.externalDocID=KR20150008931A